Zobrazeno 1 - 10
of 52
pro vyhledávání: '"T.V. Sologub"'
Autor:
O. I. Kiselev, A. B. Komissarov, O.S. Konshina, M.N. Dmitrieva, E.G. Deyeva, T.V. Sologub, V.I. Pokrovskiy
Publikováno v:
Microbiology Independent Research Journal, Vol 2, Iss 1, Pp 10-18 (2015)
The system of genetic control of innate immune responses to influenza infection and gene function allows for the development of systemic treatment of influenza with a focus on the phenotype of mutations based on individual genetic susceptibility to s
Externí odkaz:
https://doaj.org/article/6b4dc328d5864875840853f609d6bec9
Autor:
Vv, Stel Makh, Mg, Romantsov, T.V. Sologub, Aa, Shul Diakov, Vk, Kozlov, Tuan NKh, Oyungerel M, Vm, Frolov
Publikováno v:
Europe PubMed Central
Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons). The drug under the investigation was
Autor:
T.V. Sologub, Mg, Romantsov, Ts, Rybalkina, Sb, Rybalkin, An, Smagina, Va, Isakov, Al, Kovalenko
Publikováno v:
Europe PubMed Central
The study demonstrates a higher pharmacotherapeutic and economic efficacy of an alternative treatment modality for genital herpes using cycloferon, an inducer of endogenous interferons, compared with acyclovir. Clinical remission due to suppression o
Publikováno v:
Europe PubMed Central
The efficacy of the use of triple schemes in combined therapy of chronic virus hepatitis was estimated and its safety was monitored. The problems of therapy of mixed hepatitis in drug addicts are discussed. Immunotropic agents, increasing the efficac
Publikováno v:
Europe PubMed Central
The results of a study of the efficiency of treatment in patients with chronic hepatitis C conducted in a complex of multicenter clinical trials of the impact of various antiviral therapy regimens including the interferon genesis inductor cycloferon
Publikováno v:
Europe PubMed Central
During treatment of patients with chronic hepatitis B the best therapeutic effect was obtained with the inclusion in the scheme of antiviral therapy cycloferon. Complete stable remission was achieved in 54.1% of patients in combination cycloferon wit
Autor:
T.V. Sologub, Mg, Romantsov, Aa, Shul Diakov, Vg, Radchenko, Vv, Stel Makh, Al, Kovalenko, Ev, Esaulenko, Va, Isakov
Publikováno v:
Europe PubMed Central
The study including 427 patients with acute and chronic viral hepatitis was designed to assess results of clinical and laboratory diagnostics of hepatic problems and the state of thiosulfide antioxidative system. It was shown that infusion of succina
Autor:
Mg, Romantsov, T.V. Sologub, Lg, Goriacheva, Sn, Kovalenko, Ds, Sukhanov, Aa, Shul Diakov, An, Bondarenko, Al, Kovalenko, Petrov AIu
Publikováno v:
Europe PubMed Central
The aspects of virus hepatitis C immunopathogenesis are discussed. The main attention is paid to higher production of Th1 cytokines providing active protection of the host from HCV. The up-to-date approaches to the therapy of chronic hepatitis C, des
Autor:
T.V. Sologub, Lg, Goriacheva, Ds, Sukhanov, Mg, Romantsov, Tv, Antonova, Aa, Iakovlev, Vg, Radchenko, Aa, Shul Diakov, Vn, Rechnik, Aa, Suzdal Tsev, Ev, Esaulenko, Sl, Maksimov, Ip, Baranova
Publikováno v:
Europe PubMed Central
This milticentre randomized clinical study of the efficiency of remaxol infusion solution (hepatoprotective medicine for chronic liver dysfunction) included 494 patients with chronic hepatitis B and C. 294 of them staying in 7 clinics were given rema
Autor:
T.V. Sologub, Aa, Shul Diakov, Mg, Romantsov, An, Zhekalov, Sv, Petlenko, Mk, Erofeeva, Vl, Maksakova, Va, Isakov, Vv, Zarubaev, Vv, Gatsan, Al, Kovalenko
Publikováno v:
Europe PubMed Central
Data on the study of the efficacy of the tablets of cycloferon, an early inductor of types 1 and 2 interferon, in the treatment of influenza and acute respiratory tract viral infections in adults are presented. The study enrolled 522 patients with mo